(UTI) Universal Technical - Overview
Sector: Consumer Defensive | Industry: Education & Training Services | Exchange: NYSE (USA) | Market Cap: 2.206m USD | Total Return: 4.2% in 12m
Avg Turnover: 33.5M
EPS Trend: 84.8%
Qual. Beats: -1
Rev. Trend: 97.4%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
Idiosyncratic Leader
Universal Technical Institute (UTI) is a leading provider of technical and healthcare education in the United States, operating through its UTI and Concorde segments. The company specializes in delivering certificate, diploma, and degree programs designed to address labor shortages in transportation, skilled trades, and medical services.
The business model relies heavily on industry partnerships to provide manufacturer-specific advanced training (MSAT), which aligns curriculum with the technical requirements of major automotive and industrial brands. In the Education Services sub-industry, revenue is primarily driven by student enrollment volumes and federal financial aid eligibility, making regulatory compliance a critical operational factor.
Investors can evaluate the company’s valuation metrics and historical performance trends on ValueRay.
Founded in 1965 and headquartered in Phoenix, Arizona, the company maintains a national network of campuses and dedicated training centers to serve a diverse student base and various corporate partners.
- Student enrollment growth in healthcare and skilled trades drives revenue expansion
- Expansion of new campus locations increases capital expenditures and long-term capacity
- Department of Education regulatory shifts impact federal financial aid eligibility
- Skilled labor shortages increase corporate demand for manufacturer-specific training programs
- Integration of Concorde Career Colleges acquisition scales healthcare segment profit margins
| Net Income: 42.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -9.62 > 1.0 |
| NWC/Revenue: 4.13% < 20% (prev 1.71%; Δ 2.42% < -1%) |
| CFO/TA 0.10 > 3% & CFO 82.2m > Net Income 42.7m |
| Net Debt (339.7m) to EBITDA (112.0m): 3.03 < 3 |
| Current Ratio: 1.17 > 1.5 & < 3 |
| Outstanding Shares: last quarter (55.7m) vs 12m ago 0.53% < -2% |
| Gross Margin: 48.64% > 18% (prev 0.49%; Δ 4.81k% > 0.5%) |
| Asset Turnover: 110.5% > 50% (prev 108.6%; Δ 1.87% > 0%) |
| Interest Coverage Ratio: 13.25 > 6 (EBITDA TTM 112.0m / Interest Expense TTM 4.39m) |
| A: 0.04 (Total Current Assets 243.8m - Total Current Liabilities 207.9m) / Total Assets 852.2m |
| B: 0.13 (Retained Earnings 114.8m / Total Assets 852.2m) |
| C: 0.07 (EBIT TTM 58.1m / Avg Total Assets 786.3m) |
| D: 0.23 (Book Value of Equity 115.5m / Total Liabilities 512.3m) |
| Altman-Z'' = 1.45 = BB |
| DSRI: 2.31 (Receivables 96.6m/37.6m, Revenue 869.0m/782.7m) |
| GMI: 1.01 (GM 48.64% / 49.24%) |
| AQI: 0.75 (AQ_t 0.11 / AQ_t-1 0.15) |
| SGI: 1.11 (Revenue 869.0m / 782.7m) |
| TATA: -0.05 (NI 42.7m - CFO 82.2m) / TA 852.2m) |
| Beneish M = -2.05 (Cap -4..+1) = BB |
As of June 01, 2026, the stock is trading at USD 37.41 with a total of 1,244,135 shares traded.
Over the past week, the price has changed by +2.21%,
over one month by -0.32%,
over three months by +0.03% and
over the past year by +4.21%.
Universal Technical has received a consensus analysts rating of 4.83. Therefore, it is recommended to buy UTI.
- StrongBuy: 5
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 42.5 | 13.6% |
P/E Trailing = 52.7105
P/E Forward = 52.0833
P/S = 2.5383
P/B = 6.4893
P/EG = 3.4684
Revenue TTM = 869.0m USD
EBIT TTM = 58.1m USD
EBITDA TTM = 112.0m USD
Long Term Debt = 127.8m USD (from longTermDebt, last quarter)
Short Term Debt = 23.7m USD (from shortTermDebt, last quarter)
Debt = 501.7m USD (from shortLongTermDebtTotal, last quarter) + Leases 185.5m
Net Debt = 339.7m USD (calculated: Debt 501.7m - CCE 162.0m)
Enterprise Value = 2.55b USD (2.21b + Debt 501.7m - CCE 162.0m)
Interest Coverage Ratio = 13.25 (Ebit TTM 58.1m / Interest Expense TTM 4.39m)
EV/FCF = 1000.0x (Enterprise Value 2.55b / FCF TTM 1.88m)
FCF Yield = 0.07% (FCF TTM 1.88m / Enterprise Value 2.55b)
FCF Margin = 0.22% (FCF TTM 1.88m / Revenue TTM 869.0m)
Net Margin = 4.91% (Net Income TTM 42.7m / Revenue TTM 869.0m)
Gross Margin = 48.64% ((Revenue TTM 869.0m - Cost of Revenue TTM 446.3m) / Revenue TTM)
Gross Margin QoQ = 46.70% (prev 49.99%)
Tobins Q-Ratio = 2.99 (Enterprise Value 2.55b / Total Assets 852.2m)
Interest Expense / Debt = 0.87% (Interest Expense 4.39m / Debt 501.7m)
Taxrate = 25.22% (21.3m / 84.3m)
NOPAT = 43.5m (EBIT 58.1m * (1 - 25.22%))
Current Ratio = 1.17 (Total Current Assets 243.8m / Total Current Liabilities 207.9m)
Debt / Equity = 1.48 (Debt 501.7m / totalStockholderEquity, last quarter 339.9m)
Debt / EBITDA = 3.03 (Net Debt 339.7m / EBITDA 112.0m)
Debt / FCF = 180.8 (Net Debt 339.7m / FCF TTM 1.88m)
Total Stockholder Equity = 327.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.43% (Net Income 42.7m / Total Assets 852.2m)
RoE = 13.02% (Net Income TTM 42.7m / Total Stockholder Equity 327.7m)
RoCE = 12.77% (EBIT 58.1m / Capital Employed (Equity 327.7m + L.T.Debt 127.8m))
RoIC = 8.53% (NOPAT 43.5m / Invested Capital 509.4m)
WACC = 6.07% (E(2.21b)/V(2.71b) * Re(7.30%) + D(501.7m)/V(2.71b) * Rd(0.87%) * (1-Tc(0.25)))
Discount Rate = 7.30% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 95.56 | Cagr: 19.34%
[DCF] Terminal Value 73.10% ; FCFF base≈29.5m ; Y1≈25.9m ; Y5≈20.9m
[DCF] Fair Price = N/A (negative equity: EV 335.3m - Net Debt 339.7m = -4.40m; debt exceeds intrinsic value)
EPS Correlation: 84.76 | EPS CAGR: 103.6% | SUE: -2.31 | # QB: -1
Revenue Correlation: 97.40 | Revenue CAGR: 16.60% | SUE: 0.10 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.02 | Chg30d=-87.38% | Revisions=-14% | Analysts=6
EPS current Year (2026-09-30): EPS=0.77 | Chg30d=-0.61% | Revisions=+43% | GrowthEPS=-31.7% | GrowthRev=+8.9%
EPS next Year (2027-09-30): EPS=0.85 | Chg30d=-3.64% | Revisions=+0% | GrowthEPS=+9.8% | GrowthRev=+8.9%
[Analyst] Revisions Ratio: +43%